LPIN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.81854531433601E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.21089854494039E-13 |
Normal-vs-Stage2 |
1.0090817070818E-12 |
Normal-vs-Stage3 |
1.63880020664919E-12 |
Normal-vs-Stage4 |
4.10782519111308E-13 |
Stage1-vs-Stage2 |
6.899600E-01 |
Stage1-vs-Stage3 |
5.958400E-03 |
Stage1-vs-Stage4 |
4.848000E-01 |
Stage2-vs-Stage3 |
1.393170E-01 |
Stage2-vs-Stage4 |
8.620600E-01 |
Stage3-vs-Stage4 |
2.009800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.79500858621395E-12 |
Normal-vs-AfricanAmerican |
7.40985051095322E-12 |
Normal-vs-Asian |
1.5190099999951E-05 |
Caucasian-vs-AfricanAmerican |
7.443400E-01 |
Caucasian-vs-Asian |
9.769200E-01 |
AfricanAmerican-vs-Asian |
9.189400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.64313007644523E-13 |
Normal-vs-Female |
3.9235281690253E-13 |
Male-vs-Female |
5.182400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.66373598126302E-15 |
Normal-vs-Age(41-60Yrs) |
3.42914585615972E-12 |
Normal-vs-Age(61-80Yrs) |
1.69531055860261E-12 |
Normal-vs-Age(81-100Yrs) |
1.07179820574288E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.400230E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.718500E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.476400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.746270E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.667000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.467400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.963600E-03 |
Normal-vs-Grade 2 |
1.88171700443718E-12 |
Normal-vs-Grade 3 |
3.05644398679306E-13 |
Normal-vs-Grade 4 |
1.66322511319095E-12 |
Grade 1-vs-Grade 2 |
2.451800E-01 |
Grade 1-vs-Grade 3 |
2.551800E-01 |
Grade 1-vs-Grade 4 |
1.349250E-01 |
Grade 2-vs-Grade 3 |
9.239200E-01 |
Grade 2-vs-Grade 4 |
1.710550E-01 |
Grade 3-vs-Grade 4 |
1.963180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.67483821150927E-12 |
Normal-vs-ccB subtype |
1.12465592394528E-13 |
ccA subtype-vs-ccB subtype |
4.124000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.68229882749438E-13 |
Normal-vs-N1 |
1.54316999999571E-05 |
N0-vs-N1 |
4.396800E-01 |
|
|